Skip Navigation

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018

DENVER, CO - (NewMediaWire) - June 11, 2024 - Ubiquitech Software Corp. (OTC: UBQU) reported second quarter fiscal year 2024 revenue of $624,585, an increase of more than ten times compared to the prior year’s period. This increase came through revenue produced by its subsidiary, Innovative Outcomes. Ubiquitech Software Corp. announced its merger with healthcare company Innovative Outcomes on March 6, 2024, providing the opportunity to enter the medical wound care space. All other entities have been dissolved as the company now exclusively focuses on this important component of healthcare.

Kevin Lamb, CEO of Innovative Outcomes, stated: “These second quarter results represent the beginning of our integration into Ubiquitech, and as this integration is completed, we will continue our focus on the remainder of our year where we historically experience more accelerated growth. Our clinic pipeline development efforts were rewarded with many new clinic relationships during the quarter. These connections have also provided for the introduction of our clinic-based model, allowing for in-depth clinic and patient engagement. We look forward to an elevated growth rate through the rest of the year as we continue our clinic onboarding processes. I am extremely proud of and thankful to the entire Innovative Outcomes team as we deliver the most advanced products and AI-generated tutorials in the market.”

To hear Kevin Lamb’s informative interview explaining the background, business model, and projected growth of Innovative Outcomes, Inc., click the link here:

Follow Ubiquitech Software Corp, Inc. to learn more about Innovative Outcomes and stay informed about Company developments and growth:

Innovative Outcomes Inc.:

Ubiquitech Software Corp.:

Follow UBQU on X (Formerly Twitter) @CorporateUBQU

Follow Innovative Outcomes on X (Formerly Twitter) @i_outcomes

About Ubiquitech Software Corp.

Ubiquitech Software Corp utilizes its state-of-the-art global internet marketing, Metaverse marketing, Affiliate marketing, Direct Response (DRTV) Television, Radio, Internet Content, SEO, and traditional marketing to drive traffic to its subsidiary.

About Innovative Outcomes Inc.

Innovative Outcomes is one of the fastest growing healthcare logistics companies serving medical providers and their patients across the United States. Patients First is more than a catchy phrase - it’s our culture.

Our mission is simple: provide ethics-based, compassion-focused assistance to medical providers and their patients. Our iPak – unit dose packaging system makes wound care simple and intuitive for all patients.

As a leader in healthcare technology and logistics, we take the worry out of healing.

Safe Harbor

Safe Harbor Provision Cautionary Statement for purposes of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995: Information in this news release contains forward-looking statements that involve risks, uncertainties, and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of the Company and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties, and assumptions include the execution and performance of contracts by the Company and its customers, suppliers, and partners. Please also review Ubiquitech Software Corporation, Inc. annual and quarterly financials for a more complete discussion of risk factors. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise. This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.

 Contact / Investor relations